147 related articles for article (PubMed ID: 17848422)
1. Evaluation of centrally acting cholinesterase inhibitor exposures in adults.
McCain KR; Sawyer TS; Spiller HA
Ann Pharmacother; 2007 Oct; 41(10):1632-7. PubMed ID: 17848422
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
4. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors in the treatment of dementia.
Ellis JM
J Am Osteopath Assoc; 2005 Mar; 105(3):145-58. PubMed ID: 15863734
[TBL] [Abstract][Full Text] [Related]
6. Poisoning in older adults: a 5-year experience of US poison control centers.
Crouch BI; Caravati EM; Mitchell A; Martin AC
Ann Pharmacother; 2004 Dec; 38(12):2005-11. PubMed ID: 15522976
[TBL] [Abstract][Full Text] [Related]
7. Anticholinesterase duration in the Australian veteran population.
Gadzhanova S; Roughead L; Mackson J
Aust N Z J Psychiatry; 2010 May; 44(5):469-74. PubMed ID: 20397790
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.
Lockhart IA; Mitchell SA; Kelly S
Dement Geriatr Cogn Disord; 2009; 28(5):389-403. PubMed ID: 19893314
[TBL] [Abstract][Full Text] [Related]
9. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review of California poison control system data of sibutramine exposures.
Minns AB; Ebrahimi S; Te L; Ly B; Clark RF; Cantrell FL
Clin Toxicol (Phila); 2009 Sep; 47(8):814-7. PubMed ID: 19778191
[TBL] [Abstract][Full Text] [Related]
11. A retrospective poison center review of varenicline-exposed patients.
Kreshak AA; Clark AK; Clark RF; Ly BT; Cantrell FL
Ann Pharmacother; 2009 Dec; 43(12):1986-91. PubMed ID: 19934384
[TBL] [Abstract][Full Text] [Related]
12. Toxic effects from metformin exposure.
Spiller HA; Quadrani DA
Ann Pharmacother; 2004 May; 38(5):776-80. PubMed ID: 15031415
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Pediatric Exposures to Antidementia Drugs Reported to a Poison Control System.
Thornton SL; Pchelnikova JL; Cantrell FL
J Pediatr; 2016 May; 172():147-50. PubMed ID: 26935787
[TBL] [Abstract][Full Text] [Related]
14. Melatonin exposures reported to Texas poison centers in 1998-2003.
Forrester MB
Vet Hum Toxicol; 2004 Dec; 46(6):345-6. PubMed ID: 15587262
[TBL] [Abstract][Full Text] [Related]
15. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of Alzheimer's disease: past, present, and future.
Ott BR
Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092
[No Abstract] [Full Text] [Related]
17. Tramadol exposures reported to statewide poison control system.
Marquardt KA; Alsop JA; Albertson TE
Ann Pharmacother; 2005 Jun; 39(6):1039-44. PubMed ID: 15870139
[TBL] [Abstract][Full Text] [Related]
18. Anti-Alzheimer drugs: life-threatening adverse effects.
Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
[TBL] [Abstract][Full Text] [Related]
19. Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands.
Kröger E; Berkers M; Carmichael PH; Souverein P; van Marum R; Egberts T
Am J Geriatr Pharmacother; 2012 Dec; 10(6):373-80. PubMed ID: 23217530
[TBL] [Abstract][Full Text] [Related]
20. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
